首页> 外文期刊>Osteoarthritis and cartilage >Minimally clinically important improvement: All non-responders are not really non-responders an illustration from total knee replacement
【24h】

Minimally clinically important improvement: All non-responders are not really non-responders an illustration from total knee replacement

机译:临床上至少具有重要意义的改善:所有无反应者并不是真正的无反应者,全膝关节置换的示意图

获取原文
获取原文并翻译 | 示例
           

摘要

Patient-reported outcomes (PROs) are accepted endpoints in the evaluation of patient treatment. Attention has focused on defining the minimal clinically important improvement/change (MCID) of PROs as a way to identify response to treatment. Importantly, the number needed to treat that is commonly used in similar circumstances is based on the responder rate.Goldsmith et al. introduced the concept of the MCID based on expert clinical opinion in 19931. Subsequently, Jaeschke et al.2 defined the MCID as "...the smallest difference in score in the domain of interest that patients perceive as beneficial and which would mandate, in the absence of troublesome side effects and excessive cost, a change in the patient's management."
机译:在患者治疗评估中,患者报告的结局(PRO)是公认的终点。注意力集中在定义PRO的最小临床重要改善/改变(MCID),以识别对治疗的反应。重要的是,在类似情况下通常需要使用的治疗数量是基于缓解率的。在19931年基于专家的临床见解引入了MCID的概念。随后,Jaeschke等[2]将MCID定义为“ ...在患者认为是有益的且必将引起关注的关注领域中分数的最小差异。没有麻烦的副作用和高昂的费用,这改变了患者的治疗方式。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号